Coverage for in vitro fertilization and genetic testing.

Checkout our iOS App for a better way to browser and research.

Affected by 63I-2-249 on 1/1/2030

Effective 5/12/2020
49-20-420. Coverage for in vitro fertilization and genetic testing.
  • (1) As used in this section:
    • (a) "Qualified condition" means:
      • (i) cystic fibrosis;
      • (ii) spinal muscular atrophy;
      • (iii) Morquio Syndrome;
      • (iv) myotonic dystrophy; or
      • (v) sickle cell anemia.
    • (b) "Qualified individual" means a covered individual who:
      • (i) has been diagnosed by a physician as having a genetic trait associated with a qualified condition; and
      • (ii) intends to get pregnant with a partner who is diagnosed by a physician as having a genetic trait associated with the same qualified condition as the covered individual.
  • (2) For a plan year that begins on or after July 1, 2020, the program shall provide coverage for a qualified individual for:
    • (a) in vitro fertilization services; and
    • (b) genetic testing of a qualified individual who receives in vitro fertilization services under Subsection (2)(a).
  • (3) Before November 1, 2022, and before November 1 of every third year thereafter, the program shall:
    • (a) calculate the change in state spending attributable to the coverage under this section; and
    • (b) report the amount described in Subsection (3)(a) to the Health and Human Services Interim Committee and the Social Services Appropriations Subcommittee.




Download our app to see the most-to-date content.